89bio Inc (ETNB)
7.94
-0.05
(-0.63%)
USD |
NASDAQ |
Dec 24, 16:00
89bio Free Cash Flow: -280.54M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Madrigal Pharmaceuticals Inc | -438.32M |
| Eli Lilly and Co | -2.275B |
| Viking Therapeutics Inc | -74.25M |
| Akero Therapeutics Inc | -212.64M |
| NovaBay Pharmaceuticals Inc | -4.812M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -145.36M |
| Cash from Investing (Quarterly) | -8.639M |
| Cash from Financing (Quarterly) | 33.19M |
| Free Cash Flow Per Share (Quarterly) | -1.358 |
| Free Cash Flow Yield | -36.85% |